Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martinus A H Capelle

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Drug Discovery Today. Technologies|July 2, 2014
High-throughput formulation screening of therapeutic proteinsMartinus A H Capelle, Tudor Arvinte
Vaccine|February 12, 2005
Spectroscopic characterization of antibodies adsorbed to aluminium adjuvants: correlation with antibody vaccine immunogenicityMartinus A H Capelle, Peter Brügger, Tudor Arvinte
International Journal of Pharmaceutics|November 13, 2007
High throughput methods to characterize protein permeation and releaseMartinus A H Capelle, Robert Gurny, Tudor Arvinte
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 17, 2006
High throughput screening of protein formulation stability: practical considerationsMartinus A H Capelle, Robert Gurny, Tudor Arvinte
Pharmaceutical Research|July 5, 2008
A high throughput protein formulation platform: case study of salmon calcitoninMartinus A H Capelle, Robert Gurny, Tudor Arvinte
Pharmaceutics|May 27, 2026
Predictive Stability of Aggregation in Glycoconjugate Vaccines Using Advanced Kinetics Modeling and High-Throughput ScreeningTao Ju Cui, Didier Clénet, Martinus A H Capelle, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 8, 2011
Enhanced physical stability of human calcitonin after methionine oxidationFilippo Mulinacci, Emilie Poirier, Martinus A H Capelle, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 21, 2013
Influence of methionine oxidation on the aggregation of recombinant human growth hormoneFilippo Mulinacci, Emilie Poirier, Martinus A H Capelle, et al.
Journal of Pharmaceutical Sciences|March 5, 2011
Noncovalent pegylation by dansyl-poly(ethylene glycol)s as a new means against aggregation of salmon calcitoninClaudia Mueller, Martinus A H Capelle, Tudor Arvinte, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 28, 2011
Tryptophan-mPEGs: novel excipients that stabilize salmon calcitonin against aggregation by non-covalent PEGylationClaudia Mueller, Martinus A H Capelle, Tudor Arvinte, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Drug Discovery Today. Technologies|July 2, 2014
High-throughput formulation screening of therapeutic proteinsMartinus A H Capelle, Tudor Arvinte
Vaccine|February 12, 2005
Spectroscopic characterization of antibodies adsorbed to aluminium adjuvants: correlation with antibody vaccine immunogenicityMartinus A H Capelle, Peter Brügger, Tudor Arvinte
International Journal of Pharmaceutics|November 13, 2007
High throughput methods to characterize protein permeation and releaseMartinus A H Capelle, Robert Gurny, Tudor Arvinte
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 17, 2006
High throughput screening of protein formulation stability: practical considerationsMartinus A H Capelle, Robert Gurny, Tudor Arvinte
Pharmaceutical Research|July 5, 2008
A high throughput protein formulation platform: case study of salmon calcitoninMartinus A H Capelle, Robert Gurny, Tudor Arvinte
Pharmaceutics|May 27, 2026
Predictive Stability of Aggregation in Glycoconjugate Vaccines Using Advanced Kinetics Modeling and High-Throughput ScreeningTao Ju Cui, Didier Clénet, Martinus A H Capelle, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 8, 2011
Enhanced physical stability of human calcitonin after methionine oxidationFilippo Mulinacci, Emilie Poirier, Martinus A H Capelle, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 21, 2013
Influence of methionine oxidation on the aggregation of recombinant human growth hormoneFilippo Mulinacci, Emilie Poirier, Martinus A H Capelle, et al.
Journal of Pharmaceutical Sciences|March 5, 2011
Noncovalent pegylation by dansyl-poly(ethylene glycol)s as a new means against aggregation of salmon calcitoninClaudia Mueller, Martinus A H Capelle, Tudor Arvinte, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 28, 2011
Tryptophan-mPEGs: novel excipients that stabilize salmon calcitonin against aggregation by non-covalent PEGylationClaudia Mueller, Martinus A H Capelle, Tudor Arvinte, et al.
Pageof 2